Transdermal drug delivery is gathering steam as a complicated drug delivery method, especially for administering macromolecules. Several advantages they need over parenteral routes account for the rising popularity of products within the transdermal drug delivery market. Clinicians aiming at improving the pharmacokinetic profiles of medicine find this delivery route a fit, additionally to non-invasiveness of the methodology. This sideways, the market is seeing investment by pharmaceutical companies who see potential of the tactic in improving the patient compliance. Transdermal drug delivery systems are an alternate to oral intravascular, subcutaneous, and transmucosal routes, wherein the drugs are delivered through the skin for therapeutic use.

The transdermal drug delivery system market is expected to be around USD 8.25 billion by 2028, at a CAGR of 4.5%.

Increase in geriatric population and upsurge in number of patients affected by chronic disorders are expected to drive the market growth. Furthermore, increase in adoption of third-generation transdermal drug delivery systems, like iontophoresis, boosts the market growth. Nevertheless, disadvantages of those delivery systems, like irritation at the location of application and edema, are expected to impede the market progress.

Global Transdermal Drug Delivery System market is segmented based on the Application as, Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases. On the basis of Type, Patches and Semisolid formulations. The report segments global Transdermal Drug Delivery System market based on End User as Home Care Settings and Hospitals & Clinics.

Global Transdermal Drug Delivery System market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional Transdermal Drug Delivery System market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

Research Methodology:

To calculate the market size, the report considers the revenue generated from the sales of Transdermal Drug Delivery System market manufacturers. The revenue generated from the sales of Transdermal Drug Delivery System manufacturer has been calculated through primary and secondary research.

The market size estimation also considered leading players revenues as part of triangulation the key players considered are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), and GlaxoSmithKline (UK). Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).  Availability service among others operating in the Transdermal Drug Delivery System market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes types of segmentation determined using secondary sources and verified through primary sources.

The Transdermal Drug Delivery System Market has been segmented as below:

Transdermal Drug Delivery System Market, By Application

• Pain Management
• Hormonal Applications
• Central Nervous System Disorders
• Cardiovascular Diseases
• Other Applications

• Diabetes
• Smoking Cessation
• Motion Sickness
• Overactive Bladder

Transdermal Drug Delivery System Market, By Type

• Transdermal Patches 
• Transdermal Semisolids

Transdermal Drug Delivery System Market, By End User

• Home Care Settings
• Hospitals & Clinics

Transdermal Drug Delivery System Market, By Region

• North America
• Europe
• Asia Pacific
• Rest of World

Report scope:

The global Transdermal Drug Delivery System market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends. The report scope includes market analysis on regional as well as country level.

Reasons to Buy this Report:

• Gain comprehensive insights on the industry trends
• Identify industry opportunities and key growth segments
• Obtain complete market study on the Transdermal Drug Delivery System market

Below are our New Reports :-

Immunochemistry Reagents Market

Josamycin (CAS 16846-24-5) Market

Human Insulin Drugs & Delivery Devices Market

Companion Animal Vaccines Market

Foot and Mouth Disease (FMD) Vaccine Market